A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?
Journal Title: Diabetes Research – Open Journal - Year 2016, Vol 2, Issue 2
Abstract
Aim: Current guidelines suggest pursuing optimal metabolic management ever since the onset of type 2 diabetes mellitus (T2DM). Nevertheless, over 50% Italian patients fail to meet expected metabolic targets. The aim of our observational, multicenter study was to check whether this might at least partially depend on therapeutic inertia by verifying how diabetologists modified drug regimens of patients referring to them for the first time. Material and Methods: Two-thousand one hundred and eighty-eight people with T2DM aged ≥18 years and displaying a glycated hemoglobin (HbA1c) >7% (>53 mmol/mol) were analyzed at the time of their first visit at the Diabetes Care Unit (DCU). They reported no history of cardiovascular disease, were on oral hypoglycemic agents (OHA) and had clinical records available for at least the last 3 months. Results: The most relevant findings were the following: 70.3% patients underwent treatment changes after the first visit while only 0.4% had their previous drugs withdrawn. 29.7% people, however, were kept on the same regimens despite high HbA1c values and specialists reduced sulfonylurea (SU) prescriptions by only 4.3% and started insulin only in 3.8% patients, despite people with HbA1C >8% were as many as 58%. Conclusion: Even diabetologists were insufficiently fast and aggressive at intensifying glucose lowering treatment and in fact therapeutic inertia often prevented them from following best practice recommendations since the first visit. Specific actions have to be devised and readily taken against it to homogeneously improve diabetes outcomes by preventing unpredictably differentiated approaches from patient to patient. Better tools and greater resources allowing safer intensive glucose lowering strategies may also help specialists implement best practices.
Authors and Affiliations
Felice Strollo
Associations of Waist-to-Height Ratio with Various Emotional and Irregular Eating, and Making Environment to Promote Eating in Japanese Adults: The Saku Cohort Study
Objective: The waist-to-height ratio (WHtR) has started gaining attention as a measure of abdominal obesity. While the associations between various eating behaviors and high BMI or obesity or overweight determined by BMI...
Do we Need New Therapies for Diabetes?
Diabetes research and practice cluster (drug developers, payers, regulators and physicians) often (and especially in recent times) question the need of new therapies. Why would we need new therapies nowadays, when we hav...
Regulatory T-Cells in Treatment of Type-1 Diabetes: Types and Approaches
Regulatory T-cells (Tregs) play important role in regulation of immune responses to self-antigens. Alterations in frequency and function of Tregs have been reported in Type 1 Diabetes (T1D) subjects. Tregs have the poten...
Additive and Antagonistic Effects Among Combination of Agonists of Peroxisome Proliferator-Activated Receptor gamma (PPARg) on Transcriptional Activity
Objective: The Angiotensin-II receptor blocker telmisartan and sulfonylurea glimepiride may have clinical usefulness as partial agonists of PPARg. We investigated additive and antagonistic effects among combinations of t...
Population-Based Strategy for Preventing Diabetes and its Complications
A recent report from the American College of Physicians (ACP) should cause a paradigm change for the treatment of diabetic patients.1 The main purpose of diabetes therapy is the prevention of complications.2 The endpoi...